Search results for "RICS"

showing 10 items of 14086 documents

Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosi…

2015

Background: Available data suggest that pregnancy exposure to interferon-beta might result in lower mean birth weight and preterm birth. Objective: To determine the effect of interferon-beta exposure during pregnancy on pregnancy outcomes in multiple sclerosis patients. Methods: We compared the pregnancy outcomes of women exposed to interferon-beta with pregnancies unexposed to disease-modifying therapies. Women were enrolled into the German Multiple Sclerosis and Pregnancy Registry. A standardized questionnaire was administered during pregnancy and postpartum. Detailed information on course of multiple sclerosis and pregnancy, concomitant medications, delivery, and outcome of pregnancy was…

AdultPediatricsmedicine.medical_specialtyMultiple SclerosisBirth weightGerman03 medical and health sciences0302 clinical medicinePregnancyGermanymedicineBirth WeightHumansImmunologic Factors030212 general & internal medicineProspective StudiesRegistriesProspective cohort studyPregnancy registryPregnancyInterferon betabusiness.industryMultiple sclerosisInfant NewbornAbnormalities Drug-InducedInterferon-betamedicine.diseaselanguage.human_languageBody HeightAbortion SpontaneousPregnancy ComplicationsFirst trimesterPregnancy Trimester FirstNeurologylanguagePremature BirthFemaleNeurology (clinical)business030217 neurology & neurosurgeryMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

Gynecological adverse effects of natalizumab administration: Case report and review of the literature.

2018

Abstract Background Natalizumab is administered for the treatment of relapsing-remitting multiple sclerosis (RR-MS) with high disease activity.Natalizumab therapy has been associated with adverse effects, such as progressive multifocal leukoencephalopathy, liver damage, nasopharyngitis, urinary tract infection, urticaria, cephalgia, dizziness, fatigue, nausea, fever, rigidity, anxiety and gastroenteritis. Objective To describe a case of a woman with RR-MS who developed recurrent vaginitis on natalizumab administration. Methods Case report and review of the literature. Results The case of a 26-year-old Caucasian woman with RR-MS, who presented with recurrent vaginitis since the initiation of…

AdultPediatricsmedicine.medical_specialtyNauseaUrinary systemDisease03 medical and health sciences0302 clinical medicineNatalizumabMultiple Sclerosis Relapsing-RemittingmedicineHumansImmunologic Factors030212 general & internal medicineAdverse effectVaginitisbusiness.industryProgressive multifocal leukoencephalopathyMultiple sclerosisNatalizumabGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingNeurologyFemaleNeurology (clinical)medicine.symptombusinessGenital Diseases Female030217 neurology & neurosurgerymedicine.drugFollow-Up StudiesMultiple sclerosis and related disorders
researchProduct

TESTING THE EFFECT OF THE EPIDEMIOLOGIC PARADOX: BIRTH WEIGHT OF NEWBORNS OF IMMIGRANT AND NON-IMMIGRANT MOTHERS IN THE REGION OF VALENCIA, SPAIN

2013

SummaryThe epidemiological paradox and ‘healthy migrant effect’ refer to the favourable health outcomes in unprivileged groups under unfavourable socioeconomic conditions. Weight at birth is associated with the epidemiological paradox. However, differences in fertility structure (mainly mother's age and first maternity) might be the cause of the difference in weight at birth between children of immigrant and non-immigrant mothers. This paper aims to analyse the impact of the epidemiologic paradox by distinguishing between the factors related to fertility structure, in addition to other socio-cultural factors. The importance of fertility structure as the cause of weight-at-birth differences …

AdultPediatricsmedicine.medical_specialtyOffspringmedia_common.quotation_subjectBirth weightImmigrationEthnic groupEmigrants and ImmigrantsFertilityPregnancyEpidemiologyEthnicitymedicineBirth WeightHumansSocioeconomic statusmedia_commonAnalysis of VariancePregnancybusiness.industryInfant NewbornPublic Health Environmental and Occupational HealthGeneral Social Sciencesmedicine.diseaseParityFertilitySocioeconomic FactorsSpainLinear ModelsFemalebusinessMaternal AgeDemographyJournal of Biosocial Science
researchProduct

Territorial Differences in Infant Mortality in Latvia in the First Decade of the Third Millennium

2015

Objective: Infant and child mortality are some of the most substantial indicators of country welfare. Infant mortality (IM) in Latvia is constantly the highest among 25 Member States of the European Union. Since the regaining of independence in 1991, IM has decreased by almost 50%, however, it is still high enough to cause concern that the country will not be able to meet the UN Millennium Development Goals to decrease IM in Latvia by 2015. The Medical Faculty at the University of Latvia has conducted several studies identifying correlations between IM and GDP, total expenditure on health, unemployment and GINI coefficient. It is necessary to identify all IM causes and relationships which h…

AdultPediatricsmedicine.medical_specialtyPopulationRural HealthYoung AdultInfant MortalitymedicineHumansmedia_common.cataloged_instanceRegistriesEuropean unioneducationmedia_commoneducation.field_of_studyInfant NewbornUrban HealthPublic Health Environmental and Occupational HealthInfantGeneral MedicineMillennium Development GoalsSudden infant death syndromeLatviaInfant mortalityEuropeChild mortalityGeographyFemaleResidenceRural areaDemographyCentral European Journal of Public Health
researchProduct

Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: a case report

2019

Abstract Background Long-acting injectable (LAI) antipsychotics for psychotic disorders provide advantages in treatment compliance, but data on their use in pregnancy are very limited. We present a clinical case of aripiprazole LAI use in pregnancy. Case presentation A 43-year-old woman diagnosed with bipolar disorder, with several relapses due to treatment interruption while trying to conceive. Finally, aripiprazole LAI treatment was planned by mutual agreement between doctor and the patient, who took aripiprazole LAI before and during pregnancy. She gave birth at 40 weeks to a 3500 g baby girl with no congenital malformations, who was healthy at 5 months after delivery. Conclusion As far …

AdultPediatricsmedicine.medical_specialtyTime FactorsBipolar disordermedicine.medical_treatmentvirusesAripiprazoleCase Report030226 pharmacology & pharmacyInjections IntramuscularAntipsychotic03 medical and health sciences0302 clinical medicineimmune system diseasesPregnancylcsh:RA1190-1270medicineHumansPharmacology (medical)Bipolar disorderAntipsychoticlcsh:Toxicology. PoisonsPharmacologyDosage FormsPregnancybusiness.industrylcsh:RM1-950Pregnancy Outcomevirus diseasesCongenital malformationsmedicine.diseasePregnancy ComplicationsLong actinglcsh:Therapeutics. PharmacologyTreatment interruptionLong-acting injectable aripiprazoleAripiprazoleFemaleClinical casebusinessmedicine.drugAntipsychotic AgentsFollow-Up StudiesBMC Pharmacology and Toxicology
researchProduct

Study protocol: fit for delivery - can a lifestyle intervention in pregnancy result in measurable health benefits for mothers and newborns? A randomi…

2013

Abstract Background The global obesity epidemic has led to increased attention on pregnancy, a period when women are at risk of gaining excessive weight. Excessive gestational weight gain is associated with numerous complications, for both mother and child. Though the problem is widespread, few studies have examined the effect of a lifestyle intervention in pregnancy designed to limit maternal weight gain. The Fit for Delivery study will explore the effectiveness of nutritional counseling coupled with exercise classes compared with standard prenatal care. The aims of the study are to examine the effect of the intervention on maternal weight gain, newborn birth weight, glucose regulation, co…

AdultPediatricsmedicine.medical_specialtyTime FactorsComplications of pregnancyHealth StatusBirth weightMothersPrenatal carelarge for gestational ageOverweightlaw.inventionStudy ProtocolRandomized controlled triallawSurveys and QuestionnairesOutcome Assessment Health CaremedicineHumansLife Styleweight retentionPregnancyexerciseNorwaybusiness.industrylcsh:Public aspects of medicineInfant NewbornPublic Health Environmental and Occupational Healthlcsh:RA1-1270Prenatal CareVDP::Medical disciplines: 700::Health sciences: 800Overweightmedicine.diseaseGestational diabetesnutritiongestational weight gainrandomized controlled trialFemalePregnant Womenpregnancymedicine.symptomgestational diabetesbusinessWeight gainFollow-Up StudiesBMC Public Health
researchProduct

High cotinine levels are persistent during the first days of life in newborn second hand smokers.

2013

a b s t r a c t Background: Despite the adverse effects of maternal smoking during pregnancy on the newborn's health are well-known, in the pediatric population, a high prevalence exists that is very much affected by second hand smoke (SHS). This study aims to investigate the impact of maternal smoking habits during preg- nancy on cotinine levels in newborns during the first days of life. The high association between cotinine concentration in maternal and umbilical cord blood (UCB) has been previously reported, but the levels of blood cotinine that remain in infants born to smokers is unknown. Methods: Cotinine concentration was measured in UCB, in maternal and newborn peripheral blood. Dat…

AdultPediatricsmedicine.medical_specialtyTime FactorsMaternal smokingBirth weightToxicologyUmbilical cordCohort Studieschemistry.chemical_compoundYoung AdultPregnancymedicineHumansPharmacology (medical)Adverse effectCotinineMaternal-Fetal ExchangeSecond hand smokePharmacologyPregnancybusiness.industryObstetricsSmokingInfant NewbornPrenatal smokingmedicine.diseaseFetal BloodPsychiatry and Mental healthmedicine.anatomical_structurechemistryFemaleTobacco Smoke PollutionbusinessCotinineBiomarkersDrug and alcohol dependence
researchProduct

Severe chronic spontaneous urticaria in children – treatment options according to the guidelines and beyond – a 10 years review

2020

This is a retrospective study of 18 children with chronic spontaneous urticaria (CSU), where standard therapies, including up-dosing of antihistamines and omalizumab, were unable to cure the disease and where alternative strategies with experimental and off-label medication had to be used. Being aware that our questionnaire is validated only for elder children or adults, we utilized the UAS7 to monitor disease control with the help of the parents. The UAS7 score decreased from a mean of 25 to an average of 13 after 8 weeks of therapy in 13 patients. Five patients had no significant reduction of UAS7 by week 8. In two of five patients, where periodic improvement was seen, omalizumab therapy …

AdultPediatricsmedicine.medical_specialtyUrticariaDermatologyOmalizumabOmalizumab030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineimmune system diseasesAnti-Allergic AgentsmedicineHumansChronic Urticariaskin and connective tissue diseasesChildAgedRetrospective Studies030203 arthritis & rheumatologybusiness.industryTreatment optionsRetrospective cohort studyDupilumabhumanitiesbody regionsTreatment OutcomeChronic Diseasebusinessmedicine.drug
researchProduct

How to predict a high rate of inappropriateness for upper endoscopy in an endoscopic centre?

2010

Abstract BACKGROUND: Inappropriateness of upper endoscopy (EGD) indication causes decreased diagnostic yield. Our aim of was to identify predictors of appropriateness rate for EGD among endoscopic centres. METHODS: A post-hoc analysis of two multicentre cross-sectional studies, including 6270 and 8252 patients consecutively referred to EGD in 44 (group A) and 55 (group B) endoscopic Italian centres in 2003 and 2007, respectively, was performed. A multiple forward stepwise regression was applied to group A, and independently validated in group B. A <70% threshold was adopted to define inadequate appropriateness rate clustered by centre. RESULTS: discrete variability of clustered appropriaten…

AdultPediatricsmedicine.medical_specialtyappropriatnessGroup BUpper Gastrointestinal TractAge DistributionMedicineHumansAppropriatenessEndoscopy Digestive SystemendoscopyReferral and ConsultationRetrospective StudiesUltrasonographySettore MED/12 - GastroenterologiaHepatologybusiness.industryPatient SelectionUpper endoscopyupper endoscopy; appropriatness; endoscopyGastroenterologyRetrospective cohort studyStepwise regressionMiddle AgedAppropriateness Upper endoscopySettore MED/18 - Chirurgia GeneraleAppropriateness; Upper endoscopyItalyROC CurveUpper endoscopyPractice Guidelines as TopicAge distributionbusiness
researchProduct

Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden: A population‐bas…

2021

Objective: Investigate all-cause and cause-specific late mortality after childhood acute lymphoblastic leukemia (ALL) in a population-based Nordic cohort. Methods: From the cancer registries of Denmark, Finland, and Sweden, we identified 3765 five-year survivors of ALL, diagnosed before age 20 during 1971–2008. For each survivor, up to five matched comparison subjects were randomly selected from the general population (n = 18,323). Causes of death were classified as relapse related, health related, and external. Late mortality was evaluated by cumulative incidences of death from 5-year survival date. Mortality hazard ratios (HR) were evaluated with Cox proportional models. Results: Among th…

AdultPediatricsmedicine.medical_specialtycause-specific mortalityDenmarkPopulationlong-term follow-upacute lymphoblastic leukemiaDECADESCohort StudiesYoung AdultCancer SurvivorsSurvivorship curvechildhood cancerHumansMedicineCumulative incidenceeducationChildhood Acute Lymphoblastic LeukemiaFinlandSwedeneducation.field_of_studyOvertreatmentbusiness.industryHazard ratioDEATHCancer5-YEAR SURVIVORSHematologyPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseCANCERConfidence intervalREDUCTIONOncologylate mortalityPediatrics Perinatology and Child HealthCohortFOLLOW-UPbusinesssurvivorshipPediatric Blood &amp; Cancer
researchProduct